Total Ancillary
Chad Herron is an accomplished healthcare executive with extensive experience in sales, business development, and strategic management within the medical and pharmaceutical industries. Currently serving as Operating Partner at Total Ancillary since March 2019, Chad focuses on enhancing patient care through innovative biologics management. Previously, Chad held significant roles including Vice President of Sales at VisionScope Technologies, where responsibilities included driving sales for advanced medical devices, and Operating Partner at Valence Laboratories, which emphasized high-complexity laboratory testing. Chad's career also features key positions such as Chief Development Officer at Medcore Pharmacy and Vice President of Business Development at US Health Group Inc. An MBA graduate from Texas State University, Chad has consistently demonstrated a strong commitment to improving health outcomes and operational efficiency across various healthcare sectors.
This person is not in any teams
Total Ancillary
Total Ancillary is a technology driven biologics services company, passionate about making advanced wound care treatment modalities available to physicians. By simplifying the product selection process and reducing back-office workload, our industry-leading services seek to promote better clinical outcomes over traditional wound care, maximize patient coverage, reduce inherent insurance risks, and affirm consistent reimbursement.